7月2日，礼来盘中上涨3.14%，报1230.17美元/股，成交额6.83亿美元。
消息面上，制药板块当日集体走强，阿斯利康涨5.53%，诺和诺德涨4.14%，辉瑞涨2.41%，强生涨2.09%，默沙东涨2.3%。此前6月30日，礼来因减肥药首次纳入联邦医疗保险报销范围消息而回调逾3%，当前反弹或为市场重新评估该政策长期利好：Medicare GLP-1桥梁计划已于7月1日正式启动，符合条件的参保人每月仅需自付50美元即可使用Foundayo及Zepbound，潜在覆盖约1500万至2000万老年参保者，打开庞大增量市场空间。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.